Testagen (Langford Research Institute)
Welcome to the PulseAid listing for the Testagen drug offered from Langford Research Institute. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Langford Research Institute |
NON-PROPRIETARY NAME: | Testosterone |
SUBSTANCE NAME: | (1,2,6,7-3H)TESTOSTERONE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | |
ROUTE: | TRANSDERMAL |
DOSAGE FORM: | AEROSOL, SPRAY |
MARKETING CATEGORY NAME: | IND |
START MARKETING DATE: | 2016-12-30 |
END MARKETING DATE: | 0000-00-00 |
Testagen HUMAN PRESCRIPTION DRUG Details:
Item Description | Testagen from Langford Research Institute |
LABELER NAME: | Langford Research Institute |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 50(mg/50mg) |
START MARKETING DATE: | 2016-12-30 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 70304-001_44e4944f-3e81-5b60-e054-00144ff8d46c |
PRODUCT NDC: | 70304-001 |
APPLICATION NUMBER: | IND101271 |
Other (1,2,6,7-3H)TESTOSTERONE Pharmaceutical Manufacturers / Labelers: